Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals

Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals

Saved in:

Bibliographic Details
Main Authors:	Siyu Chen, Sudhir Venkatesan, Sofie Arnetorp, Klas Bergenheim, Sabada Dube, Wilhelmine Meeraus, Cátia Ferreira, Sylvia Taylor, Lisa J. White
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-06-01
Series:	PLoS Computational Biology
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129335/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network.
by: Wilhelmine Hadler Meeraus, et al.
Published: (2015-01-01)

Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period
by: Samah Hayek, et al.
Published: (2025-01-01)

Dose-dependent impact of tixagevimab–cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals
by: Daniela Dluzynski, et al.
Published: (2025-05-01)

Dysregulated Adaptive Immune Responses to SARS-CoV-2 in Immunocompromised Individuals
by: Núria Mayola Danés, et al.
Published: (2025-05-01)

Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
by: Anke L. Stuurman, et al.
Published: (2025-12-01)

The Potential Role of Recombinant Hematopoietic Colony-Stimulating Factors in Preventing Infections in the Immunocompromised Host
by: James Rusthoven
Published: (1991-01-01)

Pulmonary tuberculosis in the immunocompromised patients
by: Vukosav Danijela, et al.
Published: (2019-01-01)

Fungal Sinusitis in Immunocompromised Hosts
by: Abdulkadir Küçükbayrak, et al.
Published: (2014-08-01)

Phlegmonous duodenitis in an immunocompromised patient
by: Daisuke Miyagishima, et al.
Published: (2023-04-01)

Pneumocystosis pneumonia in immunocompromised patients
by: Beuy Joob, et al.
Published: (2020-11-01)

Pericardial Abscess in an Immunocompromised Patient
by: Marion Larue, et al.
Published: (2024-01-01)

An Immunocompromised Adult With Oral Ulcers
by: Brent Gawey, et al.
Published: (2022-11-01)

Laryngeal Histoplasmosis in an Immunocompromised Host
by: Angelina K. Winbush, et al.
Published: (2022-07-01)

A Randomized Trial of At-Home COVID-19 Tests, Telemedicine, and Rapid Prescription Delivery for Immunocompromised Individuals
by: Julia Moore Vogel, PhD, et al.
Published: (2025-06-01)

Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong
by: Desmond Y. H. Yap, et al.
Published: (2025-12-01)

Shingles in an immunocompromised child: expect the unexpected
by: Samantha Pérez-Cavazos, et al.
Published: (2023-09-01)

Combination Therapy for Cryptosporidiosis in Immunocompromised Patients
by: Wiwien Sugih Utami, et al.
Published: (2024-12-01)

49 Austrian syndrome in an immunocompromised patient
by: Jonathan Cattrall, et al.
Published: (2025-03-01)

Clues to hepatic histoplasmosis in an immunocompromised patient
by: Prashilla Soma, et al.
Published: (2009-06-01)

Histoplasmosis in Immunocompromised and Immunocompetent Patients in Guadeloupe
by: Constance Lahuna, et al.
Published: (2025-06-01)

Septic Infrapatellar Bursitis in an Immunocompromised Female
by: Kenneth Herring, et al.
Published: (2018-01-01)

Lactococcus lactis Endocarditis in an Immunocompromised Patient
by: Austin Mitchell, et al.
Published: (2022-01-01)

ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
by: George Petrikkos, et al.
Published: (2011-01-01)

ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
by: George Petrikkos, et al.
Published: (2011-03-01)

Multidrug-Resistant Bacteria in Immunocompromised Patients
by: Alexandru Duhaniuc, et al.
Published: (2024-08-01)

SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals
by: Karen Zafilaza, et al.
Published: (2025-04-01)

Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018
by: Kailey Hughes Kramer, et al.
Published: (2024-12-01)

The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling.
by: Timothy B Hallett, et al.
Published: (2008-03-01)

The Evolving Landscape of Viral Infections in Immunocompromised Hosts
by: Ralph Tayyar, et al.
Published: (2025-05-01)

Histoplasmosis misdiagnosed as malignancies in immunocompetent and immunocompromised patients
by: Ofonime E. Benjamin, et al.
Published: (2025-08-01)

Invasive fungal infections and the management in immunocompromised conditions
by: Garima Anandani, et al.
Published: (2025-07-01)

India and the conundrum of booster dose in immunocompromised patients
by: Kunal Chandwar, et al.
Published: (2022-01-01)

EFFICACY OF PNEUMOCOCCAL INFECTIONS PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
by: E. V. Galkina-Lazareva
Published: (2012-05-01)

Cycloferon in the Treatment of Immunocompromised Patients with Allergic Rhinitis
by: N. S. Tataurshchikova
Published: (2020-05-01)

MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN
by: V. I. Ignatyeva, et al.
Published: (2015-03-01)

The Giant Condyloma (Buschke-Löwenstein Tumor) in the Immunocompromised Patient
by: Andrew L. Atkinson, et al.
Published: (2014-01-01)

Immunoregulatory function of Ganoderma spore oil in immunocompromised mice
by: YI Youjin, et al.
Published: (2013-03-01)

Tamdy virus pathogenesis in immunocompetent and immunocompromised mouse models
by: Mingxue Cui, et al.
Published: (2025-12-01)

Miliary Tuberculosis in Immunocompromised Patient Induced by Imatinib and Steroid
by: Randa Fermada, et al.
Published: (2022-01-01)

Disseminated histoplasmosis induced hemophagocytic lymphohistiocytosis in an immunocompromised patient
by: N.El Bardai, et al.
Published: (2025-04-01)